Welcome to our dedicated page for Nucor SEC filings (Ticker: NUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nucor Corporation's SEC filings document operating results, governance and capital-structure matters for a NYSE-listed steel and steel products manufacturer. Recent Form 8-K reports furnish quarterly earnings releases, investor presentations and Regulation FD materials tied to the company's steel mills, steel products and raw materials operations.
The filing record also includes definitive proxy materials and current reports on officer appointments, retirements, executive employment arrangements and compensation-plan participation. Nucor's disclosures identify its common stock, par value $0.40 per share, as listed on the New York Stock Exchange under the symbol NUE.
Nucor Corporation Executive Vice President John J. Hollatz reported an option exercise-and-sale transaction in company stock. On June 3, 2026, he exercised employee stock options to acquire 10,560 shares of common stock at exercise prices of $133.03 and $130.71 per share. He then sold 10,560 common shares in open-market transactions at prices of $258.33 and $258.57 per share. Following these transactions, Hollatz directly holds 97,865.39 shares of Nucor common stock.
NUCOR CORP Executive Vice President Kenneth Rex Query reported selling a total of 13,529 shares of Nucor common stock in open-market transactions. The sales occurred on June 1, 2026 at prices around $251 per share, and reflect discretionary open-market sales of directly held shares.
West Nadja reported acquisition or exercise transactions in this Form 4 filing.
Nucor Corporation director Nadja West reported receiving a grant of 755 shares of common stock as equity compensation. The award was recorded at a price of $0.00 per share, reflecting that it was a grant, not an open-market purchase. The footnote explains these shares are tied to restricted stock units that vest immediately upon grant, with the actual shares issuable to her, or her estate, as soon as administratively practicable after her service on the board of directors ends. Following this grant, West directly holds 10,703 shares of Nucor common stock.
NUCOR CORP director Michael W. Lamach reported an acquisition of 755 shares of Common Stock as a compensation award. The award is recorded at a price of $0.0000 per share, reflecting a grant rather than an open-market purchase. Following this award, he holds 4,555 directly owned shares of NUCOR CORP common stock. The filing also shows indirect holdings of 55 shares held by a trust for the benefit of his spouse and 70 shares held by a trust for his benefit. According to the footnote, these shares are tied to restricted stock units that vest immediately upon grant, with the underlying shares issuable to him, or his estate if applicable, as soon as administratively practicable after his service on the board of directors ends.
KOELLNER LAURETTE T reported acquisition or exercise transactions in this Form 4 filing.
NUCOR CORP director Laurette T. Koellner received an equity award of 755 shares of common stock-equivalent units. The filing shows this as a grant or award with no cash price per share. Following the award, Koellner directly owns 21,193 shares of Nucor common stock.
The footnote explains that these restricted stock units vest immediately upon grant, but the underlying shares will be issued to Koellner, or to her estate if applicable, as soon as administratively practicable after her service on the board of directors ends.
KEARNEY CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.
NUCOR CORP director Christopher J. Kearney received an equity award of 755 shares of common stock as compensation. The Form 4 classifies this as a grant or award, not an open‑market purchase, with a stated price of $0.00 per share. Following the award, Kearney directly holds 46,753 common shares. According to the footnote, the grant takes the form of restricted stock units that vest immediately, while the actual shares will be issued as soon as administratively practicable after he leaves the board.
Director Nicholas C. Gangestad reported receiving an equity award from Nucor Corporation. He acquired 755 shares of common stock at a stated price of $0.00 per share as a grant, rather than an open-market purchase. According to the footnote, these shares are tied to restricted stock units that vest immediately but are issued in stock to him, or his estate, after his service on the board of directors ends. After this award, he directly holds 4,315 common shares.
NUCOR CORP director Patrick Dempsey received an equity award of 755 shares of Common Stock as board compensation. The transaction is coded as a grant or award acquisition at a price of $0.00 per share and is not an open-market purchase.
Following this award, Dempsey directly holds a total of 18,325 shares of Nucor common stock. According to the footnote, these shares are tied to restricted stock units that vest immediately upon grant, but the underlying shares are issuable as soon as administratively practicable after his service on the board of directors ends.
CLAYTON NORMA reported acquisition or exercise transactions in this Form 4 filing.
NUCOR CORP director Norma Clayton received a grant of 755 shares of Common Stock on June 1, 2026. The award is recorded at a price of $251.49 per share and is immediately vested. Following this grant, her direct holdings total 5,825.623 shares of Nucor common stock.
Although the shares vest immediately, the footnote explains they may not be sold or otherwise transferred until her service on the board of directors ends. This makes the grant a compensation-related equity award rather than an open-market purchase or sale.
Nucor Corp Chair and CEO Leon J. Topalian reported routine equity compensation and related tax withholding transactions in company common stock. On June 1, 2026, he received 12,028 shares of common stock as a grant and 18,429 stock options with a $251.49 exercise price, each option tied to one share.
The options are issuable upon vesting of restricted stock units that vest in three annual installments starting on June 1, 2027, with potential acceleration upon death, disability, retirement, or change in control. The filing also shows 17,715 shares withheld by Nucor at $250.00 per share to cover tax liabilities from previously reported restricted stock unit vestings in 2023, 2024, and 2025.
After these transactions, Topalian directly held 126,126.47 shares of common stock, plus 1,356.52 shares held indirectly through the Nucor Profit Sharing Plan, where his plan balance was $334,341.65 as of May 27, 2026.